A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis.
Infection
; 49(5): 1055-1060, 2021 Oct.
Article
in English
| MEDLINE | ID: covidwho-983887
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is a rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case of a patient diagnosed with coronavirus disease (COVID-19) who developed a pulmonary mucormycosis with extensive cavitary lesions is here reported. This case highlights how this new coronavirus might impair the immune response, exposing patients to higher risk of developing opportunistic infections and leading to worse outcomes.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Opportunistic Infections
/
Invasive Fungal Infections
/
COVID-19
/
Mucormycosis
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Infection
Year:
2021
Document Type:
Article
Affiliation country:
S15010-020-01561-x
Similar
MEDLINE
...
LILACS
LIS